Anatoliy V. Kaminskiy

Anatoliy V. Kaminskiy

Auto-generated profile, based on publicly available information

Anatoliy V. Kaminskiy

Shupyk National Healthcare University of Ukraine, Kyiv

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2021 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
VKV.V. Kaminskyi
V.V. Kaminskyi
RTR.O. Tkachenko
R.O. Tkachenko
AKA.V. Kaminskyi
A.V. Kaminskyi
OZO.I. Zhdanovych
O.I. Zhdanovych
LVL.I. Vorobei
L.I. Vorobei
SMS.I. Mudryi
S.I. Mudryi
Research objective: to study the clinical efficacy of the proposed treatment complex in pregnant women with coronavirus disease (COVID-19).Materials and methods. 60 pregnant women with a moderate COVID-19 who were treated at the Kyiv City Center for Reproductive and Perinatal Medicine were examined and selected to assess the effectiveness of the proposed treatment. Pregnant women were divided into 2 clinical groups: the main group (n = 30) were prescribed treatment complex with progestin, the comparison group consisted of 30 pregnant women with COVID-19, who did not differ in age, sex, body mass index and received only standard drug therapy. Given the immunomodulatory effect, micronized progesterone was administered orally 200 mg three times a day immediately after hospitalization for 2 weeks, regardless of gestational age. Clinical manifestations, laboratory and instrumental indicators, duration of oxygen therapy and respiratory support, duration of hospital stay and intensive care were analyzed to assess the treatment complex.Results. Therapeutic complex with progesterone helps to reduce the severity of respiratory disorders in pregnant women with COVID-19, the general condition of pregnant women improves faster and inflammatory changes in the lungs regress. The positive dynamics of pulse oximetry indicators was noted. The frequency of the additional methods of respiratory support and transfer to the intensive care unit were lower, and a more rapid normalization of laboratory parameters was noted. Incidence of gestational complications (threats of pregnancy termination, placental insufficiency, fetal growth retardation and distress, oligohydramnios, premature birth and premature rupture of membranes) was lower against the background of treatment with progesterone, children status was better at birth. The need for oxygen therapy, the length of stay in the intensive care unit and the total length of hospitalization are significantly reduced when progesterone was prescribed for pregnant women with COVID-19.Conclusions. The use of progesterone in pregnant women with coronavirus disease has a stabilizing effect, has no negative side effects which is significantly expands the scope of the proposed therapy in pregnant women at different stages of gestation.

29 October 2022 in Modern pediatrics. Ukraine
Verified
Journal Article
Closed access
ОZО.I. Zhdanovich
О.I. Zhdanovich
LVL.I. Vorobey
L.I. Vorobey
TKT.V. Kolomiichenko
T.V. Kolomiichenko
AKA.V. Kaminskyi
A.V. Kaminskyi
OLO.T. Laksha
O.T. Laksha
Through various mechanisms: increased rates of preterm birth, placental infection that can disrupt placental-fetal exchange, and through transmission of the virus in utero, during childbirth or after birth. Purpose - to determine the characteristics of the state of newborns and the neonatal period, depending on the severity of the mother’s illness with COVID-19. Materials and methods. Under observation were 14 newborns (group 1), whose mothers were ill with severe COVID-19 and needed intensive care in the department of anesthesiology and intensive care, and 46 children from mothers with moderate COVID-19, who were treated in the infectious diseases and obstetrics department (group 2). Results. In mothers with COVID-19, especially when the disease is severe, the fetus is exposed to direct and indirect negative effects of a viral infection, which is confirmed by signs of placental insufficiency in the vast majority of pregnant women (71.4%) and its clinical manifestations in the form of distress and fetal growth retardation (50.0% and 35.7%, respectively), placental dysfunction was confirmed pathohistologically. Dangerous for the fetus are oligohydramnios in 50.0% of women up to ahydramnios (14.3%), preeclampsia (14.3%), caesarean section (57.1%), premature rupture of fruit membranes (14.3%) and preterm birth (28.0%). 42.9% of children are born in a state of asphyxia, with 14.3% having severe asphyxia, 35.7% of children were born weighing less than 2500 g. A positive test for COVID-19 was observed in 7.1% of newborns. 21.4% of children were diagnosed with pneumonia, 35.7% had respiratory distress syndrome. Children from mothers with COVID-19 have a high incidence of maladaptation syndromes (64.3%). In addition to RDS, there was a high incidence of neurological disorders (57.1%) in the form of a syndrome of depression, gastrointestinal syndrome (50.0%), thermoregulation disorders (42.9%), and 35.7% had hypoglycemic and hemorrhagic syndromes. Necrotizing enterocolitis was diagnosed in children with pneumonia on the 5-7th day of life. Conclusions. Disorders in children from mothers with COVID-19 at birth and a high incidence of maladjustment syndromes, the risk of health and cognitive impairment in the future necessitate further scientific research, active follow-up of this new cohort of children and the development of prevention and rehabilitation measures. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.

10 July 2020 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
LSL. V. Suslikova
L. V. Suslikova
VKV. V. Kaminskyi
V. V. Kaminskyi
KCK. V. Chayka
K. V. Chayka
AKA. V. Kaminskyi
A. V. Kaminskyi
ASA. V. Serbeniuk
A. V. Serbeniuk
OBO. Y. Bondaruk
O. Y. Bondaruk
Objective: optimization of pregravid (pre-pregnancy) preparation in patients with tubal-peritoneal infertility factor and marked delay in endometrial development after unsuccessful assisted reproductive technology (ART) treatment by the use of endometrium injection scratching technology with autoplasma.Material and methods. Study included 40 cases of unsuccessful treatment attempts for tubal-peritoneal factor infertility with severe delay of endometrial development and 10 patients with tubal-peritoneal factor infertility with normal endometrium with one or more unsuccessful ART attempts on history and the existence of cryopreserved embryos of satisfactory quality from previous cycles of assisted reproductive technology. The average age was 39.5 ± 3.1 years. Patients were divided into groups: I – 21 patients who underwent endometrial injection scratching and hormonе replacement therapy (HRT) with a standard (4/6 mg) dose of estradiol; II – 19 patients who were prescribed HRT with a standard (4/6 mg) dose of estradiol; control – 10 patients with normal endometrium who underwent cryo-ET with standard (4/6 mg) dose of estradiol.Clinical results were evaluated and compared in terms of pregnancy rate per embryo transfer and pregnancy loss rate in the first trimester. The correspondence of the morphofunctional structure of the endometrium was evaluated by ultrasound, cytologically, Doppler measurements, histologically, immunohistochemically and via selective electron microscopy. Endometrium was 8.9 ± 1.1 mm during the period of progesterone prescription in the cryoembryo transfer cycle. All participants were transferred day 5 embryos. Results. In the cryo-ET program autoplasma injection scratching in patients with marked delay of endometrial development after the first seven days of monotherapy with a starting dose of estradiol was accompanied by a significant improvement in clinical outcomes in terms of pregnancy rate (25%) and definite decrease of early reproductive losses (25%).Conclusions. After pre-pregnancy preparation according to our method, it is quite sufficient to perform HRT with a standard dose of estradiol (4/6 mg/day) before starting progesterone irrespective of the endometrial development degree. Meanwhile, injection scratching is advisable to be prescribed in cases of marked delay in the endometrium development and it should be combined with physiotherapy methods.

30 September 2025 in Reproductive health of woman
Verified
Journal Article
Open access
PDF file
AKA.V. Kaminskyi
A.V. Kaminskyi
ASA.V. Serbeniuk
A.V. Serbeniuk
IMI.V. Malysheva
I.V. Malysheva
YLY.V. Lukianchenko
Y.V. Lukianchenko
MMM.V. Maistrenko
M.V. Maistrenko
ЮЛЮ.в. Лук’янченко
Ю.в. Лук’янченко
The objective: to develop and implement a comprehensive, ethically sound, and scientifically validated strategy to ensure access to high-quality reproductive medical services for all citizens in need.Materials and methods. A survey of 553 obstetrician-gynecologists and general practitioners (family medicine) was conducted and analyzed.Results. We conducted a study and analyzed literature sources authored by both domestic and international experts, including guidelines from Ukrainian state institutions and global medical societies specializing in fertility health. Additionally, we carried out a survey of 553 obstetrician-gynecologists and general practitioners – family doctors. The collected data from the literature and our survey were then compared. This study revealed that the majority of physicians choose patient management strategies for infertility in accordance with recommendations from the international medical community.Conclusions. A national consensus on the management of patients with infertility should assist practicing physicians in matters of diagnosis and the development of treatment strategies for this patient cohort.

30 July 2025 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
TKTetiana V. Kolomiichenko
Tetiana V. Kolomiichenko
AKAnatoliy V. Kaminskiy
Anatoliy V. Kaminskiy
IKIgor L. Kovalenko
Igor L. Kovalenko
OCOksana Chayka
Oksana Chayka
VKValeriy V. Konoplyanko
Valeriy V. Konoplyanko
Aim: To evaluate the effectiveness of determining the fertile window in women with idiopathic infertility based on the results of crystallization of saliva samples obtained using the Ovul portable device with a mobile application by comparing them with the results of urine test strips and folliculometry data.Material and methods: The menstrual cycles of 42 women with idiopathic infertility were analyzed: Group I - 21 women who took drugs to induce ovulation, Group II - 21 women with natural menstrual and ovarian cycles. Ovulation was confirmed or excluded based on the results of the Ovul device, urine test strips, and folliculometry.Results: Although ovulation detection using the Ovul device and urine test strips has 100% specificity, the sensitivity of the device is 97.4%and the accuracy is 97.6% (if the positive result is ovulation or the fertile window), while for urine test strips the sensitivity is 94.9% and the accuracy is 95.2% if we consider a positive result not only to be the same as the day of ovulation according to folliculometry, but also a positive result within the next 72 hours (mainly 12-24).Conclusions: Ovulation detection using the Ovul device is a highly accurate, 100% specific and highly sensitive method that can be used at home, will optimize diagnostics, make it more convenient and cheaper for patients who want to get pregnant or, on the contrary, who are trying to avoid pregnancy.

27 May 2026
Verified
Journal Article
Open access
YLYu.V. Lukianchenko
Yu.V. Lukianchenko
IMI.V. Malysheva
I.V. Malysheva
AKA.V. Kaminskyi
A.V. Kaminskyi
MSM.N. Shalko
M.N. Shalko
RBR.м. Bogachev
R.м. Bogachev
Female infertility remains a major challenge in contemporary reproductive medicine. Thyroid pathology and dysfunction significantly contribute to its development, affecting ovarian reserve, menstrual cycle, implantation processes, and the pregnancy course.The objective: to evaluate retrospective assessment of the impact of functional and structural thyroid disorders on fertility indicators in women of reproductive age.Materials and methods. A retrospective observational study was performed involving 400 women with infertility. Group I included women with thyroid dysfunction (n = 150), group II comprised women with structural thyroid changes and preserved euthyroid status (n = 220), and group III (control) consisted of women without thyroid pathology (n = 30). Serum concentrations of thyroid-stimulating hormone (TSH), free thyroxine (T4), follicle-stimulating hormone, thyroid peroxidase antibodies, and thyroglobulin antibodies were measured. All participants underwent ultrasound examination of the thyroid gland and pelvic organs to evaluate ovarian reserve and endometrial thickness. Pregnancy complications were analyzed.Results. In women with thyroid dysfunction the highest prevalence of anovulation, reduced ovarian reserve, elevated TSH, decreased free T4, and presence of thyroid autoantibodies were found. The pregnancy rate within 1 year in this group was the lowest. Moreover, anemia, threatened miscarriage, placental dysfunction, intrauterine growth restriction, and threatened preterm birth were significantly more common.Conclusions. Thyroid dysfunction in infertile women is associated with reduced fertility and an increased rate of obstetric complications, emphasizing the need for comprehensive thyroid screening in preconception care.